Jushi Holdings Inc. (JUSHF) Q1 2026 Earnings Call Transcript
Jushi Holdings Inc. (JUSHF) Q1 2026 Earnings Call Transcript
JUSHF - Jushi Holdings Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$1.93
DETAILS
HIGH:
$2.35
LOW:
$1.50
MEDIAN:
$1.93
CONSENSUS:
$1.93
UPSIDE:
328.89%
Stock News
Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Beats Revenue Estimates
Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.09 per share a year ago.
Jushi Holdings Inc. Reports First Quarter 2026 Financial Results
Revenue of $66.4 million , Up 4% Year-over-Year, Driven by Strong Wholesale Growth and Benefits from Retail Expansion Gross Profit Margin Expanded 460 bps Year-Over-Year to 45.0% , Reflecting Improved Operational Performance at our Grower-Processor Facilities Completed Strategic Refinancing, Strengthening Liquidity and Positioning the Company for Long-Term Growth BOCA RATON, Fla., May 12, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the first quarter ended March 31, 2026 (“Q1 2026”).
James Cacioppo Files Updated Early Warning Report
BOCA RATON, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- James Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi Holdings Inc. (the "Company"), announced today that he has filed an early warning report on Form 62-103F1 in connection with his acquisition of subordinate voting shares of the Company ("Subordinate Voting Shares") on December 11, 2025.
Jushi Holdings Inc. (JUSHF) Expected to Beat Earnings Estimates: Should You Buy?
Jushi Holdings Inc. (JUSHF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2026, after the market closes on Tuesday, May 12, 2026.
2 Marijuana Stocks That May Continue To Run
Now that cannabis has been rescheduled as a class 3 substance, companies are looking to find ways to get ahead. This policy change is monumental and historic overall. But it still leaves the actual plant illegal under federal law, with only certain privileges under this new bill. Even with things still in the works after the recent signing into law, marijuana stocks have been on the rise. Now, this has been seen before, with promising news and speculation creating a spike in the market.
Jushi Holdings Inc. Announces Proposed Continuance from British Columbia to Nevada
BOCA RATON, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, announced its intention to seek shareholder approval of a proposed arrangement (the "Arrangement") which involves, among other things, the continuance of the Company out from the province of British Columbia, Canada and the concurrent domestication of the Company in the State of Nevada in the United States (the "Continuance").
Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act
BOCA RATON, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, applauds President Donald J. Trump and his administration for finalizing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act. This bold and historic action represents a clear example of promises made and promises kept. The administration's move reflects a commonsense commitment to listening to science, advancing medical research and delivering meaningful reform. This continues to put an America First approach to work by supporting American patients, businesses and communities. This milestone marks one of the most significant federal cannabis policy shifts in decades, formally recognizing the medical value of cannabis and advancing long-overdue regulatory modernization. Rescheduling cannabis does not legalize cannabis at the federal level but it is a meaningful step toward destigmatizing the plant, unlocking federally supported research and expanding patient access. It also removes burdensome tax penalties and creates significant opportunities for reinvestment into the cannabis state programs which will continue to fuel job creation, economic growth and increased tax revenue for state and local communities.
Jushi Holdings Inc. (JUSHF) Q4 2025 Earnings Call Transcript
Jushi Holdings Inc. (JUSHF) Q4 2025 Earnings Call Transcript
Jushi Holdings Inc. (JUSHF) Reports Q4 Loss, Tops Revenue Estimates
Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.06 per share a year ago.
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Revenue of $262.9 Million for Full Year 2025, Up 2% Year-Over-Year, Reflecting Contributions from New Store Openings
3 Marijuana Stocks To Build A Stronger Portfolio
The cannabis industry is bringing much more attention to itself with every progressive step. Legal cannabis worldwide is becoming more accepted and treated like any other legitimate industry. This also brought in people looking to get involved in the sector. For most, this comes in the form of finding the best marijuana stocks to buy. However, if you are new to cannabis investing, there are steps that need to happen. First, you need to learn about pot stocks and which cannabis companies are publicly traded and dominating the industry.
Reviewing Brainsway (NASDAQ:BWAY) & Jushi (OTCMKTS:JUSHF)
Jushi (OTCMKTS:JUSHF - Get Free Report) and Brainsway (NASDAQ: BWAY - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 21.7% of Jushi shares are
Jushi Holdings Inc. Refinances Former 1st Lien Credit Facility and Former 2nd Lien Credit Facility with US$160 Million Non-Dilutive Debt Financing
Adds Cash to the Balance Sheet The Company to Report Fourth Quarter 2025 Financial Results on March 31, 2026 BOCA RATON, Fla., March 27, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, announced that it has completed the refinancing (the “Refinancing”) of its former senior secured credit facility (the “Former 1st Lien Credit Facility”) and its former second lien credit facility (the “Former 2nd Lien Credit Facility”) through the issuance of a $160 million senior secured term loan (the “Term Loan”) with funds managed by FocusGrowth Asset Management, along with other members of a loan syndicate.
Jushi Holdings Inc. Announces First Settlement in Ongoing Hemp-Derived THC Litigation
BOCA RATON, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, today announced that its subsidiaries Agape Total Health Care Inc., Franklin Bioscience – Penn LLC, and Franklin Bioscience – SE LLC (collectively, the “Jushi Subsidiaries”) have entered into a Settlement Agreement and Mutual Release with Revelry Supply, Inc. (“Revelry”) effective February 11, 2026, favorably resolving claims asserted in litigation pending in the Court of Common Pleas of Philadelphia County, Pennsylvania.
Jushi Holdings Inc. Announces Grand Opening of Second Beyond Hello™ in Cincinnati, Ohio, Expanding its Statewide Retail Footprint
A Media Snippet accompanying this announcement is available by clicking on this link.
Jushi (OTCMKTS:JUSHF) versus InMode (NASDAQ:INMD) Head-To-Head Survey
InMode (NASDAQ: INMD - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Valuation and Earnings This table compares InMode and Jushi"s
Price Targets
Jushi Holdings price target raised to $1.50 from $1.25 at Canaccord
$1.50
(was $0.69)
Bobby Burleson
·
Canaccord Genuity
Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Raises Price Target to $2.35
$2.35
(was $1.72)
Cantor Fitzgerald
Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Lowers Price Target to $2.25
$2.25
(was $1.92)
Cantor Fitzgerald
Cannabis Reform Is 'By Far The Main Catalyst,' Analyst Discusses Jushi's Q4 Financial Results
$2.50
(was $1.90)
Pablo Zuanic
·
Cantor Fitzgerald